Allergic fungal sinusitis: pathophysiology, diagnosis and management

Author(s): Schubert MS

Abstract

Allergic fungal sinusitis (AFS) is a noninvasive form of fungal rhinosinusitis with an incidence of between 6 and 9% of all rhinosinusitis requiring surgery. Regional variation in incidence has been reported, with the southern and southwestern US particularly endemic. Patients with AFS commonly present with chronic rhinosinusitis with nasal polyps, inhalant atopy, elevated total serum immunoglobulin E (IgE), and sinus-obstructing inspissates of a characteristic extramucosal 'peanut buttery' visco-elastic eosinophil-rich material called 'allergic mucin' that contains sparse numbers of fungal hyphae. Sinus CT is always abnormal, showing findings of chronic rhinosinusitis that often include central areas of increased contrast ('hyperattenuation') within abnormal paranasal sinuses that represent the presence of fungal-containing allergic mucin. AFS has been found to be analogous in several ways to allergic bronchopulmonary aspergillosis (ABPA). Both are chronic inflammatory respiratory tract disorders that are driven by hypersensitivity responses to the presence of small numbers of extramucosal fungi found growing within airway-impacting allergic mucin. AFS allergic mucin typically cultures positive for either dematiaceous fungi such as Bipolaris spicifera or Curvularia lunata, or Aspergillus species such as A. fumigatus, A. flavus or A. niger. As with ABPA, patients have type I immediate hypersensitivity to the etiologic mold in AFS. Further, both AFS and ABPA have been found to have association with specific class II major histocompatibility alleles. Proper diagnosis of AFS and differentiation from the other forms of both noninvasive and invasive fungal rhinosinusitis requires strict adherence to published diagnostic criteria. Medical treatment of AFS has been modeled to an extent after treatment approaches for ABPA that includes the use of postoperative oral corticosteroids and aggressive antiallergic inflammation therapy. The use of follow-up measurements of total serum IgE during treatment of both AFS and ABPA patients can help to monitor disease activity. Future AFS research will lead to further insights into pathogenesis, improved treatments, and ultimately decreases in surgical recurrence rates for this highly recurrent hypertrophic rhinosinusitis disorder.

Similar Articles

The diagnosis and incidence of allergic fungal sinusitis

Author(s): Ponikau JU, Sherris DA, Kern EB, Homburger HA, Frigas E, et al.

Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis

Author(s): Ponikau JU, Sherris DA, Kita H, Kern EB

Striking deposition of toxic eosinophil major basic protein in mucus: implications for chronic rhinosinusitis

Author(s): Ponikau JU, Sherris DA, Kephart GM, Kern EB, Congdon DJ, et al.

Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies

Author(s): Chakrabarti A, Denning DW, Ferguson BJ, Ponikau J, Buzina W, et al.

'Eosinophilic fungal rhinosinusitis': a common disorder in Europe? Laryngoscope 113: 264-269

Author(s): Braun H, Buzina W, Freudenschuss K, Beham A, Stammberger H

Allergic Aspergillus sinusitis: a newly recognized form of sinusitis

Author(s): Katzenstein AL, Sale SR, Greenberger PA

Chronicrhinosinusitis: an enhanced immune response to ubiquitous airborne fungi

Author(s): Shin SH, Ponikau JU, Sherris DA, Congdon D, Frigas E, et al.

Aspergillosis of the nose and paranasal sinuses

Author(s): Milroy CM, Blanshard JD, Lucas S, Michaels L

Localised invasive sino-orbital aspergillosis: characteristic features

Author(s): Sivak-Callcott JA, Livesley N, Nugent RA, Rasmussen SL, Saeed P, et al.

Killing of Aspergillusfumigatus by alveolar macrophages is mediated by reactive oxidant intermediates

Author(s): Philippe B, Ibrahim-Granet O, Prévost MC, Gougerot-Pocidalo MA, Sanchez Perez M, et al.

Aspergillosis of the sphenoid sinus simulating a pituitary tumor

Author(s): Larranaga J, Fandiño J, Gomez-Bueno J, Rodriguez D, Gonzalez-Carrero J, et al.

Allergic aspergillus sinusitis with proptosis

Author(s): Daghistani KJ, Jamal TS, Zaher S, Nassif OI

New species in Aspergillus section Terrei

Author(s): Samson RA, Peterson SW, Frisvad JC, Varga J

A water-damaged home and health of occupants: a case study

Author(s): Thrasher JD, Gray MR, Kilburn KH, Dennis DP, Yu A

Molds and mycotoxins in indoor environments--a survey in water-damaged buildings

Author(s): Bloom E, Nyman E, Must A, Pehrson C, Larsson L

Co-occurrence of toxic bacterial and fungal secondary metabolites in moisture-damaged indoor environments

Author(s): Taubel M, Sulyok M, Vishwanath V, Bloom E, Turunen M, et al.

Trichothecenemycotoxins in the dust of ventilation systems in office buildings

Author(s): Smoragiewicz W, Cossette B, Boutard A, Krzystyniak K

Mycotoxins in crude building materials from water-damaged buildings

Author(s): Tuomi T, Reijula K, Johnsson T, Hemminki K, Hintikka EL, et al.

Expression of markers shared between human haematopoietic cells and neuroblastoma cells

Author(s): Ebener U, Wehner S, Cinatl J, Gussetis ES, Kornhuber B

Leukophysin: a 28-kDa granule membrane protein of leukocytes

Author(s): Abdelhaleem MM, Hatskelzon L, Dalal BI, Gerrard JM, Greenberg AH

Pathogenesis II: fungal responses to host responses: interaction of host cells with fungi

Author(s): Mendes-Giannini MJ, Taylor ML, Bouchara JB, Burger E, Calich VL, et al.

Detection of fungal organisms in eosinophilicmucin using a fluorescein-labeled chitin-specific binding protein

Author(s): Taylor MJ, Ponikau JU, Sherris DA, Kern EB, Gaffey TA, et al.

Mycotoxin detection in human samples from patients exposed to environmental molds

Author(s): Hooper DG, Bolton VE, Guilford FT, Straus DC

A water-damaged home and health of occupants: a case study

Author(s): Thrasher JD, Gray MR, Kilburn KH, Dennis DP, Yu A

Aspergillus bronchitis without significant immunocompromise

Author(s): Chrdle A, Mustakim S, Bright-Thomas RJ, Baxter CG, Felton T, et al.

Aspergillusterreus complex: an emergent opportunistic agent of Onychomycosis

Author(s): Fernandez MS, Rojas FD, Cattana ME, Sosa Mde L, Mangiaterra ML, et al.

Invasive Aspergillusterreus sinusitis with orbitocranial extension: case report

Author(s): Akhaddar A, Gazzaz M, Albouzidi A, Lmimouni B, Elmostarchid B, et al.

Clinical features and outcomes of four patients with invasive fungal sinusitis

Author(s): Takahashi H, Hinohira Y, Hato N, Wakisaka H, Hyodo J, et al.

Detection of mycotoxins in patients with chronic fatigue syndrome

Author(s): Brewer JH, Thrasher JD, Straus DC, Madison RA, Hooper D

Mixed mold mycotoxicosis: immunological changes in humans following exposure in water-damaged buildings

Author(s): Gray MR, Thrasher JD, Crago R, Madison RA, Arnold L, et al.

Fungal rhinosinusitis and imaging modalities

Author(s): Gorovoy IR, Kazanjian M, Kersten RC, Kim HJ, Vagefi MR